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S1PR2 variants associated with 
auditory function in humans and 
endocochlear potential decline in 
mouse
Neil J. Ingham1,2, Francesca Carlisle1, Selina Pearson1, Morag A. Lewis1,2, Annalisa Buniello1,2, 
Jing Chen1,2, Rivka L. Isaacson3, Johanna Pass1,2, Jacqueline K. White1, Sally J. Dawson4 & 
Karen P. Steel1,2
Progressive hearing loss is very common in the population but we still know little about the underlying 
pathology. A new spontaneous mouse mutation (stonedeaf, stdf ) leading to recessive, early-onset 
progressive hearing loss was detected and exome sequencing revealed a Thr289Arg substitution in 
Sphingosine-1-Phosphate Receptor-2 (S1pr2). Mutants aged 2 weeks had normal hearing sensitivity, 
but at 4 weeks most showed variable degrees of hearing impairment, which became severe or profound 
in all mutants by 14 weeks. Endocochlear potential (EP) was normal at 2 weeks old but was reduced by 
4 and 8 weeks old in mutants, and the stria vascularis, which generates the EP, showed degenerative 
changes. Three independent mouse knockout alleles of S1pr2 have been described previously, but 
this is the first time that a reduced EP has been reported. Genomic markers close to the human S1PR2 
gene were significantly associated with auditory thresholds in the 1958 British Birth Cohort (n = 6099), 
suggesting involvement of S1P signalling in human hearing loss. The finding of early onset loss of EP 
gives new mechanistic insight into the disease process and suggests that therapies for humans with 
hearing loss due to S1P signalling defects need to target strial function.
Progressive hearing loss is the most common sensory deficit in the human population and can begin at any age, 
but we know very little of the underlying molecular or cellular mechanisms involved. Any genes found to be 
involved in progressive hearing loss can give insight into the molecular pathways and pathological processes lead-
ing to deafness. Mouse mutants are valuable tools to provide candidate genes as well as opportunities for detailed 
mechanistic investigation of the disease process.
Sphingosine-1-phosphate (S1P) signalling is known to be required for normal auditory function from studies 
of deaf mouse mutants. Mutation of the S1P transporter Spns2 leads to rapidly-progressive loss of auditory sensi-
tivity1 and three independent null mutations of the S1P receptor S1pr2 have severe elevations in auditory thresh-
olds before 4 weeks old2–4. S1P is a lysophospholipid intermediate in the process of degradation of sphingolipids, 
but it also acts as a signalling molecule with effects both within the cell and outside5,6. Extracellular S1P signals 
through five different receptors, S1pr1–5, which in turn activate a variety of intracellular signalling pathways 
via G-proteins7. S1P signalling has been implicated in a range of functions including lymphocyte trafficking6,8,9, 
macrophage and mast cell function10,11, angiogenesis12, vascular permeability and tone13 and bone remodelling14. 
It is not clear which if any of these functions is involved in normal hearing.
Here we report a missense mutation in S1pr2 that arose spontaneously in mice generated by a large scale 
targeted mutagenesis program15,16. We describe the identification of the causative mutation in the S1pr2 gene 
by linkage analysis and exome sequencing, the rapidly progressive hearing loss associated with a decline in the 
endocochlear potential, and subsequent loss of cochlear hair cells. Furthermore, we found that genomic vari-
ants close to the human S1PR2 gene were significantly associated with auditory thresholds in a large population 
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sample, the 1958 British Birth Cohort. The new mouse mutant we report here provides mechanistic insight into 
the pathological processes underlying S1PR2-related hearing loss.
Results
As part of the Sanger Institute Mouse Genetics Project, new lines of mutant mice on a C57BL/6N genetic back-
ground are screened at 14 weeks old using an electrophysiological test of hearing, the Auditory Brainstem 
Response (ABR)16,17. In one line carrying a targeted disruption of the Mms22l gene (MMS22-like, DNA repair 
protein), most mice had normal ABR thresholds (n = 7), but others (n = 4) showed no response to sound stimuli, 
including one wildtype littermate used as a control. The deafness phenotype was isolated in a new mouse colony 
and showed transmission consistent with monogenic autosomal recessive inheritance with full penetrance. We 
named the mutant allele stonedeaf (stdf ).
The stdf mutation was mapped to a 10 Mbp interval of proximal chromosome 9 by linkage analysis of offspring 
from a [(stdf/stdf x C3HeB/FeJ)F1 x stdf/stdf ] backcross. DNA from two distantly-related affected mice was sub-
mitted for exome sequencing and the data filtered and analysed (Tables 1–5). A large number of small structural 
variations were detected by Pindel across the whole genome. After filtering, 4 remained in the critical 10 Mbp 
region, but they were not located in coding regions, and were not confirmed by capillary sequencing. Two were 
present in the ancestral ES cell line (Table 3). Single nucleotide variants (SNVs) called by SAMtools were filtered 
as described (Table 4). Only 7 were within the critical 10 Mbp region (Tables 4 and 5). Of those 7 SNVs, only three 
Gene Col5a3 Slc44a2 Rgl3 n/a
Position 9:20607549–20607551 9:21149853–21149855 9:21786028–21786030 9:24346521–24346523
Type Deletion Deletion Deletion Deletion
Size 1 bp 1 bp 1 bp 1 bp
Genetic location intronic intronic intronic Intergenic
Capillary sequencing 
results Deletion not confirmed Deletion not confirmed Deletion not confirmed Deletion not confirmed
In ancestral ES cell 
line No Yes Yes No
F primer CATAGCTGGTTTGTGCATGG GCGCAAAAGGATATTGATCG AGAAGAGCTCCTGGGTAGGG CCACATGTTCTGGACTTTGC
R primer AGAGCCTGCGACAGTAGAGC AGGTCACCAGTGGGTAGAGC CAGAGCTCCTGGACTTCAGC CCTCTGAAGGTTTGGAAAGG
Table 3.  Filtered indels identified by Pindel and the primers used to check each by capillary sequencing. 
Details of the four variations identified by Pindel which are present in both homozygous mice, have above 
average quality scores and are within the critical region, and the primers used to test each by capillary 
sequencing.
Mouse ID: SD8.2c SD23.1 g
Type of sequencing Paired end Paired end
Read length 79 bp 79 bp
Number of reads mapped 92726592 106900816
Mean depth 120.88x 139.48x
Coverage of bases in Agilent exons 99.88% 99.89%
Coverage of bases in Agilent exons 
to a depth of 10 fold or more 98.88% 99.11%
Coverage of bases in Agilent exons 
to a depth of 20 fold or more 96.24% 97.10%
Table 1.  Details of Exome Sequencing.
Analysis: Software Reference
Mapping to reference 
sequence (NCBIm37) bwa 0.5.9 42
Local realignment around 
insertions and deletions GATK 1.1–5 43,44
Lane merging and marking of 
duplicate fragments picard 1.47 45, http://picard.sourceforge.net
Single nucleotide variant 
identification SAMtools 0.1.17 46
Small structural variant 
identification Pindel 0.2.4d 47
Table 2.  Details of exome analysis. Steps of exome sequencing analysis and the software used at each stage.
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were in coding regions; one was synonymous (in Rdh8) and the other two resulted in amino acid changes. One 
of the two nonsynonymous SNVs (in Bmper) was found in the ancestral ES cell line used in the creation of the 
knockout from which the stonedeaf allele arose (Table 5) and the SNV (A > C substitution producing an amino 
acid change of T570P) was predicted to be neutral, so we considered this to be an unlikely candidate. The remain-
ing SNV (a G > C transition in S1pr2; Fig. 1A), resulted in a threonine to arginine change (T289R), which was 
predicted by both NetDiseaseSNP18 and PhD-SNP19,20 to be deleterious. The affected threonine residue is highly 
conserved (Fig. 1B,D), located in a transmembrane domain, and was predicted by ConSurf 21,22 to be structural 
(Fig. 1C). Genotyping a large population (n = 204) of mice from the stonedeaf colony for this mutation by capil-
lary sequencing supported its causative nature; all mice with raised thresholds (>4 weeks old) were homozygous 
for the mutation, whereas mice with normal thresholds were either S1pr2+/stdf or S1pr2+/+.
S1pr2 was subjected to protein structure prediction using Phyre223, based on the X-Ray crystal structure of 
homologous receptor, S1pr124 and the T289R mutation was introduced using Pymol™ (DeLano Scientific LLC) 
(Fig. 1E–I). The mutation sits within a hydrophobic pocket and is likely to cause some local disruption including 
changing available hydrogen bonds (Fig. 1H,I). The mutation site (289T) is situated on the boundary between 
the membrane and intracellular region of the receptor. It might be anticipated that the replacement of threonine 
at position 289 with an arginine residue would have little effect on the protein’s position within the membrane. 
However, membrane proteins are often highly sensitive to mutation and modest differences in the tilt angle of the 
transmembrane region relative to the membrane surface, or slight changes in insertion depth have been known to 
cause significant effects on function (several such cases have been reviewed25). In S1pr2, the position of the snor-
kelling helix just above the aberrant arginine residue may be affected which might perturb intracellular signalling 
function (See Fig. 1E–G). The structural modelling therefore supports our conclusion that the T289R mutation 
is the stdf causal mutation.
Immunohistochemistry was used at postnatal day (P)5 and P14 (Fig. 2) to reveal expression of S1pr2 mainly 
in the cell bodies of inner and outer hair cells (Fig. 2C,D), and in the stria vascularis and spiral ligament fibrocytes 
which are important for the recycling of ions into the scala media (Fig. 2B,F), and in spiral ganglion cells. The 
same pattern of expression was observed at P28 (data not shown). S1pr2 expression was detected with a similar 
distribution in the S1pr2stdf/stdf mutants (Fig. 2E), which is not surprising as the point mutation is unlikely to stop 
protein translation.
Changes in auditory sensitivity with age were assessed by ABRs17, using capillary sequencing to assign geno-
type (Fig. 3A–C). Mice homozygous for the stonedeaf mutation demonstrated a wide range of auditory sensitivity 
at 4 weeks old (Fig. 3A), while thresholds were higher at 8 and 14 weeks old (Fig. 3A–C). For some of these mice 
Processing steps Number of DNA changes
Input files 695728/775792
Mapping quality ≥45 and read depth ≥10 3200/3466
Present in both homozygotes 1556
Not present in dbSNP128 or the 17 wildtype strains 1164
On chromosome 9 46
Within mapped region 7
Exonic 3
Nonsynonymous 2
Not present in ES cells 1
Table 4.  Filtering steps applied to SNVs called by SAMtools. SNVs were filtered first by quality and then by 
presence or absence in affected and wildtype mice, then by genomic location, predicted effect and presence in 
ancestral ES cells. The filter is described in the left-hand column and the number of SNVs remaining after each 
filter step is shown on the right.
Gene name Taf1d Fat3 Zfp426 Col5a3 Rdh8 S1pr2 Bmper
Position 9:15116608 9:15834189 9:20280762 9:20602750 9:20627812 9:20772109 9:23211238
Reference T G CGTGTGTGTGTGTGT GTGTGTGTGTGTGT
AACACACACACACACACACAC 
ACACACACACACACACACACAC C G A
StoneDeaf C T CGTGTGTGTGTGT GTGTGTGTGTGTGT
AACACACACACACACACACA 
CACACACACACACACACACAC T C C
Type SNV SNV 2bp deletion 2bp deletion SNV SNV SNV
Location Intronic Intronic Intronic Intronic Exonic Exonic Exonic
Zygosity Homozygote Heterozygote Heterozygote Heterozygote Homozygote Homozygote Heterozygote
Consequence  
(if in coding region) synonymous T289R T570P
In ancestral ES cell line Yes No No Yes No No Yes
Table 5.  Filtered SNVs identified in the critical region on chromosome 9. Details of the SNVs which passed 
the first five filtering steps in Table 4. They had a high mapping quality and read depth, were present in both 
mice sequenced, were not present in any wildtype strains or dbSNP128, and were within the mapped region.
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Figure 1. The stonedeaf mutation is a G > C transition in S1pr2 leading to a threonine to arginine 
substitution. (A) Trace showing the G > C SNV in wildtype (top), heterozygote (middle) and homozygote 
mutant (bottom) mice. (B) The base at 9:20772109 (indicated in red) is conserved between mouse, human, 
xenopus and zebrafish. Note that S1pr2 is on the reverse strand, and so the G > C SNV appears as C > G when 
the sequence is oriented in the direction of reading of the gene, as in A and B in this figure. (C) ConSurf analysis 
of the residues; 289T is predicted to be buried (b) and highly conserved, and thus likely to be a structural 
residue (s). (D) ConSurf-annotated clustal of S1pr2 protein sequences. 289T is highly conserved. In (C,D), 
yellow lettering indicates insufficient data for a reliable calculation of conservation. (E) Structural model of the 
wildtype S1pr2 protein based on Phyre2 modelling from the S1pr1 structure. The seven transmembrane helices 
are shown in different colours. A black arrow points to the snorkelling helix (coloured red) referred to in the 
text. (F) A zoomed view of the wildtype 289T residue (green stick form) (G). A zoomed view of the Arginine 
residue (red stick form) in the T289R substitution of S1pr2stdf. The effect of the mutation on the S1pr2 hydrogen 
bond network (based on Phyre2 modelling) is shown in H and I. (H) In the wildtype, T289 (purple) forms 
a single hydrogen bond (dotted line) with V286 (brown). (I) In the S1pr2stdf mutation, R289 (purple) can no 
longer form a hydrogen bond with V286 (brown) or any other residues.
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(n = 62), ABR measurements were made longitudinally at 4, 8 and 14 weeks old (Fig. 3D). A progressive deterio-
ration in threshold with increasing age was apparent in S1pr2stdf/stdf mice (n = 28). Wildtype (n = 7) and heterozy-
gous (n = 27, not shown) mice maintained good sensitivity of threshold as age increased.
Expression of S1pr2 in the lateral wall of the cochlear duct suggested a potential role for S1P signalling in gen-
eration of the high resting potential, the endocochlear potential (EP), in the endolymph bathing the upper surface 
of the sensory hair cells. EP is essential for normal hair cell function, providing a strong driving force across trans-
duction channels. We measured EP in mice aged P14, P28 and P56, in some cases following ABR recording. In 
P14 mice, ABR thresholds of S1pr2stdf/stdf mice were comparable to those recorded in S1pr2+/stdf littermate controls 
(Fig. 4A). EPs recorded were also of comparable magnitude in S1pr2stdf/stdf mice (98.0 ± 12.5 mV) and S1pr2+/stdf 
littermate controls (100.0 ± 11.8 mV) (Fig. 4D). At P28, ABR thresholds of control mice were maturing towards 
adult levels, but homozygous mutants demonstrated a wide range of sensitivity (Fig. 4B). At P28, EP in control 
(heterozygote) mice had reached fully mature levels (125.5 ± 6.5 mV) but mutants demonstrated a reduced and 
variable EP (47.9 ± 22.2 mV) (Fig. 4E). At P56, ABR thresholds of mutants showed further elevations compared 
to littermate controls (Fig. 4C) and EP remained low (53.7 ± 17.9 mV). Littermate control heterozygotes main-
tained normal EPs at P56 (120.5 ± 9.8 mV) (Fig. 4F). In summary, at early stages of the pathological process, ABR 
thresholds increase in line with the reduction in EP.
The stria vascularis on the lateral wall of the cochlear duct is the major site of EP generation, through active 
pumping of K+ ions into the endolymph. As EP was reduced in mutants, we examined the stria vascularis in 
whole mount preparations labelled with isolectin GS-IB4 to highlight capillaries and phalloidin to indicate fil-
amentous actin at the boundaries of the marginal cells lining the luminal surface of the stria1. We examined 
strial samples from mice aged P14, P28 and P56. Strial marginal cell boundaries appeared normal in stonedeaf 
homozygotes at P14 (Fig. 4G,H). However, at P28, these boundaries were less regular in mutants than in hete-
rozygous controls, showing a mixture of larger and smaller boundaries, typically losing their normal hexagonal/
pentagonal shapes (Fig. 4I,J). These changes were seen intermittently with some normal segments in between. 
This structural defect progressed with age. At P56, some extremely large or small marginal cell boundaries were 
seen (Fig. 4K,L). Strial capillaries displayed clear dilation in patches in some of the mutants, which was not seen 
in any of the controls (Fig. 5A–F).
Kcnj10 is an ATP-sensitive inward rectifying K+ channel which plays a crucial role in the movement of K+ 
into the endolymph to establish the high [K+] and positive EP26, so we looked for expression in the stria vascularis 
of stonedeaf mutants at P5 and P28. Expression appeared as strong in mutants as in controls at P5 but by P28, 
immunolabelling was weaker in the basal turn of mutants compared with controls (Fig. 5G–J).
No gross anatomical defects were found in the middle ear, ossicles or inner ear in stonedeaf mutants. The 
organ of Corti was then examined by scanning electron microscopy. All mice were ABR-tested one week before 
fixation and later genotyped by sequencing. In five-week-old mutants, some abnormalities of the organ of Corti 
Figure 2. Immunohistochemical localisation of S1pr2. (A–C) Expression pattern of S1pr2 in the wildtype 
cochlea at P5 (brown staining indicates S1pr2 labelling). S1pr2 is mainly expressed in scattered cells of the stria 
vascularis (black arrowheads in C), the developing spiral ligament (red arrowheads in C), Outer Hair Cells 
(OHCs, black arrowheads in B), cells of the spiral ganglion (arrows in B) and spiral ganglion neuron terminals 
innervating the Inner Hair Cells (IHCs, open arrowheads in B). (D,E) S1pr2 cochlear expression at P14 in 
stonedeaf mutant (S1pr2stdf/stdf ) and littermate controls (S1pr2+/stdf ). We detect expression of S1pr2 mainly 
in spiral ligament fibrocytes (red arrowheads), OHCs (bracket), individual cells in the stria vascularis (black 
arrowhead), basilar membrane (red arrows) spiral ganglion cells (arrows) and spiral ganglion neuron terminals 
below the IHCs (green arrowheads). We did not detect a difference in S1pr2 expression distribution, or any 
obvious difference in labelling intensity, between stonedeaf mutants and littermate controls. F: Expanded view 
of S1pr2 expression in the spiral ligament fibrocytes (red arrowheads). Scale Bars: (A,D–F) 20 μm. (B,C) 10 μm.
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were noted only in severely impaired S1pr2stdf/stdf mice. Homozygotes with click thresholds of 95dB SPL, or with 
no ABRs at all, showed OHC degeneration from the middle turn of the cochlea towards the base, while homozy-
gotes with click thresholds at or better than 80dB SPL appeared to have largely normal organs of Corti (Fig. 6). 
Degeneration of hair cells was much more extensive in 9-week-old affected mice. Only the extreme apical 10–20% 
of the organ of Corti retained some inner and outer hair cells in S1pr2stdf/stdf mice at this age and there was exten-
sive degeneration in more basal regions (data not shown). A base-to-apex gradient in hair cell degeneration is a 
common pathological pattern.
We next asked if the targeted Mms22l mutation had any impact upon the auditory phenotype. Following 
identification of the stdf mutation, mice with ABR data were divided according to both the S1pr2 genotype and 
the Mms22l genotype (n = 73 mice aged 4 weeks, 118 mice aged 8–10 weeks, 14 mice aged 44 weeks). However, 
the presence or absence of the targeted Mms22l allele did not significantly affect ABR thresholds within any S1pr2 
genotype and age group (Mann-Whitney Rank Sum Test, p > 0.05 in all cases).
To assess the possibility that other phenotypes were associated with the S1pr2stdf mutation, we obtained DNA 
samples from 39 mice from the Mms22l line that had been screened as part of the Mouse Genetics Project16. 
These samples were genotyped for the S1pr2stdf mutation and mice grouped into new cohorts that were wildtype 
(n = 10), heterozygous (n = 17) and homozygous (n = 12) for the S1pr2stdf mutation. Phenotyping data for 252 
parameters measured across 22 broad assay groups16 were obtained for these 39 mice and analysed to determine 
significant phenotypes. A summary of these data are shown in Fig. 7 as a heatmap, with data for the stonedeaf 
mutants alongside that of the Mms22l mutants and of Spns2, another mutant line affecting an S1P transporter pro-
tein involved in the same signalling pathway and with a similar auditory phenotype1. The S1pr2stdf mutation had 
a selective effect only on hearing, and showed no other abnormalities over the range of phenotyping tests (the red 
box in Fig. 7 indicating abnormal neurological features results from a lack of Preyer reflex, the ear flick response 
to sound, which is part of the neurological assessment). The targeted Mms22l allele led to lethality in homozy-
gotes, so heterozygotes were screened but no other anomalies were detected other than the three individuals that 
were deaf and later proved to be homozygous for the stonedeaf mutation. In contrast, the Spns2 mutants showed 
deafness and a number of additional abnormal phenotypes (Fig. 7), including eye defects1 and various anomalies 
of the immune system, especially associated with leucocytes9. S1P signalling effects on the immune system and 
on retinal angiogenesis are mediated through the S1pr1 gene (for example27–30) and similar deficiencies would not 
be expected in the S1pr2stdf mutant mouse.
Finally, we investigated the potential involvement of S1PR2 in human hearing loss by asking if variants in this 
gene show association with auditory thresholds in the 1958 British Birth Cohort31. Hearing thresholds measured 
at 1 and 4 kHz at the age of 44–45 and genotype data imputed to the 1000 Genomes dataset (March 2012 release) 
were used in this association study. Both datasets were available for 6,099 individuals. SNPs within 0.1 Mb of the 
S1PR2 gene as well as within the gene itself were interrogated as a candidate gene association. For 1 kHz audio-
metric thresholds, the adjacent SNP rs74930654 (which is 27 kb from the end of S1PR2, on the reverse strand) 
showed the most significant association, with a p value of 0.001644. For 4 kHz thresholds, the most significant 
association was with rs201930568 (located 100 kb before the start of S1PR2, on the reverse strand), with a p value 
0.001105. These findings suggest that variants affecting the S1PR2 gene do contribute to auditory thresholds in 
the UK population.
Discussion
Stonedeaf is a new missense mutation of S1pr2 with early-onset, progressive hearing loss with no other phe-
notypes apparent besides the hearing defect. The earliest detected changes in the cochlea were the reduced EP 
measurements and morphological changes of the stria vascularis. The appearance of hair cell degeneration in 
Figure 3. Auditory Brainstem Response (ABR) thresholds in S1pr2stdf mice. (A–C) Mean ABR thresholds 
(±SD) recorded in S1pr2+/+ (green), S1pr2+/stdf (blue) and S1pr2stdf/stdf (red) mice aged 4 weeks old (A, S1pr2+/+ 
n = 7, S1pr2+/stdf n = 34, S1pr2stdf/stdf n = 44), 8 weeks old (B, S1pr2+/+ n = 20, S1pr2+/stdf n = 75, S1pr2stdf/stdf 
n = 71) and 14 weeks old (C, S1pr2+/+ n = 7, S1pr2+/stdf n = 26, S1pr2stdf/stdf n = 25). Individual homozygous 
mouse thresholds are plotted as grey symbols and lines to emphasise the scatter of the data. (D) Click thresholds 
recorded longitudinally in S1pr2+/+ (green, n = 7), and S1pr2stdf/stdf (red, n = 28) mice are plotted as a function of 
age (from 4–14 weeks).
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stonedeaf mice appeared to be a secondary phenomenon, occurring after the onset of pathological changes to the 
stria vascularis, EP and ABR thresholds. Indeed, normal-looking hair cells were seen in the apex of the cochlea in 
5- and 9-week-old mice with no measureable ABRs. Secondary hair cell degeneration resulting from a reduced EP 
has been described before in mouse mutants where (unlike S1pr2) there is no expression of the mutant gene in the 
hair cells, such as in mice with mutations of the Kit gene32. A normal EP level may be critical for the maintenance 
of the sensory hair cells, which are specialised to survive in an environment where their upper surface is bathed in 
endolymph, so any change in voltage or ionic composition of endolymph may disrupt their homeostasis. S1pr2 is 
expressed in hair cells so we cannot rule out a direct effect of the mutation on hair cells, but as the earliest cochlear 
defect we saw was the reduction in EP, this is likely to be the primary pathological event leading to raised ABR 
thresholds and secondary hair cell degeneration.
The changes we observed in the strial blood vessels may reflect a primary change due to abnormal S1P 
signalling, which has previously been reported to have an impact on vascular tone of the modiolar artery33. 
Figure 4. Auditory Brainstem Responses (ABR), Endocochlear Potential (EP) and strial structure in 
stonedeaf mice. Left column: Mean ABR thresholds are plotted for mice aged P14 (A), P28 (B) and P56 (C), 
for control S1pr2+/stdf mice (blue) and for mutant S1pr2stdf/stdf (red). Individual S1pr2stdf/stdf thresholds are given 
shown as grey symbols and lines , to illustrate the range of data. Middle column: EP measurements with mean 
±SD. Right columns: Whole mounts of middle turn stria vascularis with filamentous actin (green) and marginal 
cell nuclei (blue); scale bar = 20 μm. (A) In P14 mice, ABR thresholds of S1pr2stdf/stdf mice (red) (n = 6) were 
comparable to those recorded in S1pr2+/stdf littermate controls (blue) (n = 10). (D) P14 EPs recorded were also of 
comparable magnitude in S1pr2stdf/stdf mice (n = 13; mean EP ± SD = 98.0 ± 12.5 mV; range 81.3–114.9 mV) and 
S1pr2+/stdf littermate controls (n = 20; mean EP ± SD = 100.0 ± 11.8mV; range 88.9–120.9 mV). (G,H) P14 strial 
marginal cell boundaries had a similar appearance in S1pr2+/stdf controls and in S1pr2stdf/stdf mice. (B) At P28, 
ABR thresholds of S1pr2+/stdf control mice were maturing towards adult levels (n = 16), but those of S1pr2stdf/stdf 
mutants (n = 16) demonstrated a wide range of sensitivity. (E) At P28, EP in S1pr2+/stdf control mice had reached 
fully mature levels (n = 16; 125.5 ± 6.5 mV, range 116.0–136.6 mV) but S1pr2stdf/stdf mutants demonstrated a 
reduced and variable EP (n = 16; 47.9 ± 22.2 mV, range 22.4–98.5 mV). (I,J) Strial marginal cell boundaries in 
P28 S1pr2stdf/stdf mice started to become less regular (panel J) compared to those of S1pr2+/stdf controls (panel I). 
(C) At P56, ABR thresholds of S1pr2stdf/stdf mutants (n = 14) showed further elevations compared to littermate 
controls (n = 7). (F) Mean EP from P56 mutant mice remained low (n = 20; 53.7 ± 17.9 mV, range 1.6–84.2 mV) 
while S1pr2+/stdf control mice maintained normal EPs (n = 12; 120.5 ± 9.8 mV, range 91.8–130.9 mV). (K,L) 
Strial marginal cell boundaries became more irregular at P56 in mutants.
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Figure 5. Capillary expansion and Kcnj10 expression in the stria vascularis of S1pr2stdf mice. Capillaries 
in the middle turn stria vascularis of mutants, shown for S1pr2stdf/stdf mutants (B,D,F) and in S1pr2+/+ 
littermate controls (A,C,E) at P14 (A,B), P28 (C,D) and P56 (E,F). Capillaries appeared swollen at P28 and 
P56 in S1pr2stdf/stdf mutants (D) compared to S1pr2+/+ littermate controls (C). Panels A–F were imaged at the 
same magnification; scale bar (in F): 20 μm. Kcnj10 (brown label) was expressed at P28 in the stria vascularis 
intermediate cells in both S1pr2stdf/stdf mutants (H,J) and in S1pr2+/+ littermate controls (G,I), in the apical and 
basal turns of the cochlea. Labelling appeared strongest towards the apex (G,H) and less strong towards the base 
(I,J). Scale Bars (G–J): 10 μm. Sections of the entire inner ear were examined, n = 3 mice for each genotype.
www.nature.com/scientificreports/
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Alternatively, the dilation we see may be a consequence of abnormal strial function, leading to both reduced EP 
and compensatory changes of the vasculature in response to local metabolic demand. Previous reports of mutants 
with strial dysfunction due to a lack of intermediate cells suggest that the strial vasculature responds to metabolic 
demand leading to small capillaries where the stria is not functional34.
The pattern of reduced EP and altered strial morphology early in the progression of the hearing loss is very 
similar to that seen in mice with a mutation of Spns2, another component of S1P signalling1. A progression 
to fewer, larger marginal cells has been described previously in ageing BALBc and CBA/CaJ mice as their EP 
becomes lower35,36 and in other mutant mice with EP defects such as the pendrin mutant37. Three independent 
knockout alleles of S1pr2 have been reported previously2–4, and disrupted marginal cell boundaries and expanded 
strial capillaries were described in one of these mutant lines3 although no EP measurements were made. These 
knockout mice all showed more severe hearing impairment than we see in the stonedeaf mutant, although none 
of them reported thresholds as early as P14 so it is not clear if there was normal development followed by very 
rapid loss of sensitivity. We find thresholds are normal in S1pr2stdf homozygotes at P14, and by P28 there is con-
siderable variability in thresholds despite all the mice having the same genetic background (C57BL/6N) and being 
housed in identical environmental conditions. In two targeted null alleles of S1pr2, severe hearing impairment 
was reported in all mice tested at P222 or 4 weeks old3, so the stonedeaf missense mutation may produce a hypo-
morphic effect on S1pr2 function and slower progression of the phenotype. The three null alleles of S1pr2 were 
also reported to show severely abnormal stria vascularis morphology, vestibular defects and progressive spiral 
ganglion loss. We did not see any indications of vestibular defects in S1pr2stdf homozygotes, but we did find stria 
vascularis structural defects that progressed with age and were similar to those previously reported in a null 
allele3.
In conclusion, we report here for the first time that EP is reduced resulting from an S1pr2 mutation, a feature 
that was not reported in the three knockout S1pr2 mutants. Furthermore, we found that the S1pr2stdf homozy-
gotes show normal thresholds and EP around the onset of hearing, progressing over the following few weeks to 
severe or profound deafness, greatly reduced EP and presumed secondary hair cell degeneration. The delayed 
loss of auditory function seen in S1pr2stdf homozygotes suggests that the functional processes mediated through 
S1P-signalling are not critical for the development of hearing, but instead are required for the ongoing mainte-
nance of cochlear function once hearing has been established. This suggests the possibility of therapeutic inter-
vention to prevent the hearing loss if diagnosed early in the pathological process. This is particularly relevant 
Figure 6. ABR data from individual mice with corresponding scanning electron micrographs. ABR 
thresholds from one S1pr2+/stdf mouse (A) and two S1pr2stdf/stdf mice (E,I) recorded at four weeks with scanning 
electron micrographs from the same mice at five weeks old. (B–D) show the apical, middle and basal turns 
respectively of the S1pr2+/stdf mouse; the corresponding best frequency for each region illustrated is indicated 
on the audiogram (A). (F–H) likewise show the apical, middle and basal turns of the S1pr2stdf/stdf mouse whose 
audiogram is shown in (E), with the corresponding frequencies marked. Although this mouse has raised 
thresholds, the organ of Corti appears normal. (J–L) show the apical, middle and basal turns of a S1pr2stdf/stdf 
mouse with no response to stimuli at all (I). No hair cells are visible in the basal turn (L), but some remain in the 
mid-apical (K) and apical (J) turns. Scale bar = 10 μm.
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given the recent discovery of missense mutations in human S1PR2 38 and our discovery of significant association 
between genomic markers close to the S1PR2 gene and auditory thresholds in the human population. These find-
ings emphasize the need for accurate diagnosis and development of treatments to restore EP in such cases where 
S1P signalling is implicated; simply attempting to regenerate hair cells, for example, would not restore hearing if a 
patient has a pathology involving EP decline. Discussion and research on developing treatments for hearing loss 
often focus on sensory hair cells, but our report provides the first clear example of the involvement of S1PR2 in EP 
generation and the need to restore EP if treatments are to be successful.
Materials and Methods
Ethics statement. Mouse studies were carried out in accordance with UK Home Office regulations and 
the UK Animals (Scientific Procedures) Act of 1986 (ASPA) under UK Home Office licences, and the study was 
approved by the King’s College London Ethical Review Committees. Mice were culled using methods approved 
under these licences to minimize any possibility of suffering.
Origin and identification of mutant allele. The stonedeaf (stdf ) mutation arose in mice derived from the 
Sanger Institute Mouse Genetics Project, which uses targeted ES cells to generate new mutant lines as described 
previously15,16. The mutation was mapped by linkage analysis of offspring from a [(stdf/stdf x C3HeB/FeJ)F1 x stdf 
/stdf ] backcross using ABR thresholds at 8–10 weeks old to assign phenotype (n = 79 affected and 82 unaffected 
offspring). DNA from two distantly-related affected mice was submitted for exome sequencing using the Agilent 
SureSelectXT mouse all exon kit for sequence capture, sequenced on the Illumina HiSeq 2000 platform and the 
data filtered and analysed as specified in Tables 1–5. The sequences have been deposited at ENA, accession num-
ber ERP000739. Mutant mice are available through EMMA.
Modelling the mutation. S1pr2 was subjected to protein structure prediction using Phyre2 (Protein 
Homology/analogY Recognition Engine version 2.023). The coordinates corresponding to the top hit, which was 
Figure 7. A heatmap to indicate significant phenotyping parameters obtained for the spontaneous mutant 
line S1pr2 and 2 targeted mutant lines, Spns2 and Mms22l. Red cells indicate which of 22 phenotyping assays 
had at least one parameter that was significantly affected compared to controls. Blue cells indicate no difference to 
controls. The yellow cell for Mms22l indicates the assay (ABR) where results did not segregate with the targeted 
genotype and led to the identification of the stonedeaf mutation. The red cell indicating abnormal neurological 
features results from a lack of startle response or Preyer reflex, the ear flick response to sound, which is part of the 
neurological assessment; all other neurological tests gave normal responses. The phenotypic differences noted are 
numbered as follows: 1. Elevated ABR thresholds, 2. Abnormal Bacterial Shedding, 3. Abnormal eye coloration, 
4. Abnormal corneal opacity, corneal vascularisation, eyelid closure, iris pupil shape, 5. Abnormal startle 
response, 6. Abnormal % B Cell CD19+, % Granulocyte Gr1+, % Mature B Cell IgD+, % Monocyte, % NK Cell, 
% NKT Cell, % T Cell CD3+, % T Cell CD4+, % T Cell CD8+, 7. Abnormal % B Cell CD19+, % Granulocyte 
Gr1+, % Mature B Cell IgD+, % Monocyte, % T Cell CD3+, % T Cell CD4+, % T Cell CD8+, 8. Abnormal 
glucose, total bilirubin, 9. Abnormal white blood cell count, 10. Abnormal viability at weaning, 11. Homozygotes 
show recessive lethality. (Details of these phenotyping platforms can be found in ref. 16).
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based on the X-Ray crystal structure of homologous receptor, S1pr124, were used to produce a model of S1pr2 and 
to introduce the T289R mutation using Pymol™ (DeLano Scientific LLC).
Immunohistochemistry. Inner ears of wildtype mice from the C57BL/6J strain carrying an albino muta-
tion (C57BL/6BrdTyrc-Brd) at postnatal day five (P5) and S1pr2stdf/stdf mutants (with littermate S1pr2+/stdf controls) 
at P14 and P28 were fixed and processed for immunohistochemistry. Sagittal wax sections, 8 μm thick, were 
exposed to rabbit anti-S1pr2 (21180-1-AP; Proteintech, Chicago, USA, 1:25), or anti-KcnJ10 (APC-035, Alomone 
Labs, Jerusalem, 1:300) antibody, before undergoing a DAB reaction and counterstaining with hematoxylin on 
a Ventana Discovery machine. Sections covering the entire inner ear for three different mouse samples of each 
genotype/age were examined.
Electrophysiology. Auditory sensitivity was assessed using measurements of Auditory Brainstem Responses 
(ABRs)17. ABRs were recorded from Ketamine/Xylazine anaesthetised mice aged 4, 8 and 14 weeks, evoked by 
clicks and tone pip (6–30 kHz) stimuli presented freefield at 0–95 dB SPL in 5 dB steps to determine threshold 
sensitivity. EPs were measured under urethane anaesthesia (2 mg/g) in a different group of mice, in some cases 
following ABR threshold measurement. After these ABR recordings, a tracheal cannula was inserted and the bulla 
was opened to allow fenestration of the cochlear wall and insertion of a 150 mM KCl-filled glass micropipette into 
the scala media. The EP was measured as the potential difference between the scala media and a reference silver/
silver chloride pellet under the dorsal skin of the neck39.
Stria vascularis analysis. Inner ears were fixed in 4% paraformaldehyde at room temperature for 2 hours 
before the lateral walls were dissected out in PBS. Samples for cell boundary analysis were incubated with 488 phal-
loidin (1:400, Molecular Probes) in PBS at room temperature for 2 hours (P14, S1pr2+/stdf n = 4; S1pr2stdf/stdf n = 3; 
P28, S1pr2+/stdf n = 7; S1pr2stdf/stdf n = 7; P56, S1pr2+/stdf n = 6; L, S1pr2stdf/stdf n = 6). For capillary analysis, whole 
mount samples were isolated and incubated with isolectin GS-IB4, 594 (Molecular Probes, 1:50) at 4 °C, overnight 
in PBS with 3% BSA, to visualise capillaries (P14, S1pr2+/stdf , n = 4; S1pr2stdf/stdf, n = 3; P28, S1pr2+/stdf , n = 4; 
S1pr2stdf/stdf, n = 5; P56, S1pr2+/stdf , n = 4; S1pr2stdf/stdf, n = 5). The samples were mounted with Vectashield Mounting 
medium with DAPI (Vector, Cat. No: H-1200) and imaged by confocal microscopy (Zeiss LSM 510 & 710). 
The numbers of capillary branch points per field (200 × 200 μm fields) in the middle turn of the cochlear duct was 
quantified using image J (controls, n = 4; homozygotes, n = 5, at P28).
Scanning electron microscopy. Samples were taken from S1pr2+/stdf and S1pr2stdf/stdf mice aged 5 and 9 
weeks old, a week after ABR testing at 4 and 8 weeks old respectively, and processed for scanning electron micros-
copy of the apical surface of the organ of Corti using the OTOTO methodology40. Samples were analysed accord-
ing to their percentage distance from the cochlear base.
Human population analysis. The 1958 British Birth Cohort and the collection of hearing data and anal-
ysis have been described previously41. Participants were drawn up from 17,638 individuals born in England, 
Scotland, and Wales in 1 week of March 1958. Of the original cohort, 9377 members were revisited by a research 
nurse for a biomedical follow-up in 2002–2004. Hearing measure consisted of pure tone audiometry at 1 kHz 
and 4 kHz at age 44–45 years and were adjusted for sex, nuisance variables (noise at test, nurse performing test, 
audiometer used in test), conductive loss, and hearing loss in childhood. DNA was collected from 6099 individ-
uals and genotyped on various Illumina and Affymetrix SNP chips (for detail see http://www2.le.ac.uk/projects/
birthcohort/1958bc/available-resources/genetic). These data were then imputed to the 1000 Genomes haplotypes 
(release March 2012) using MACH and Minimac. Measured SNPs with >95% call rate and Hardy–Weinberg 
p-value >0.0001 were included as input set. In subsequent analysis imputed SNPs with low imputation quality 
(r2-hat < 0.3 or MAF < 1%) were omitted. Individual associations were performed to hearing thresholds at 1 kHz 
and 4 kHz.
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